ADCC-Enhanced anti-ACE (9B9) is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform. By reducing the fucosylation of the Fc region, the ADCC-enhanced antibody shows an increased binding affinity for the FcyR receptor on immune effector cells. ADCC-Enhanced anti-ACE biobetter https://adcc.creative-biolabs.com/adcc-enhanced-anti-ace-biobetter-1017.htm
Proudly hosting 6067655 Images.
To use all the features of this site you must be logged in. If you don't have an account you can sign up right now.